Aurora Cannabis Inc. (NYSE: ACB) reported third quarter 2021 earnings results today. Total revenues fell 25% year-over-year to CAD55.1 million. Adjusted EBITDA
Categories
Medical Cannabis
Cronos Group (CRON) Earnings: 4Q20 Key Numbers
Cronos Group Inc. (NASDAQ: CRON) reported fourth quarter 2020 earnings results today. Net revenue more than doubled year-over-year to $17 million, driven
Tilray Inc (TLRY) Q4 2020 Earnings Call Transcript
Tilray Inc (NASDAQ: TLRY) Q4 2020 earnings call dated Feb. 17, 2021. Corporate Participants: Raphael Gross -- Investor Relations Brendan Kennedy --
HEXO Corp. (HEXO) Earnings: 1Q21 Key Numbers
HEXO Corp. (NYSE: HEXO) reported its first quarter 2021 earnings results today. Net revenue rose 103% year-over-year to CAD29.5 million. Net loss
Canopy Growth Corporation (CGC) Q2 Earnings: Key financials and quarterly highlights
Canopy Growth Corporation (NYSE: CGC) reported second quarter 2021 earnings results today. Net revenues increased 77% year-over-year to CAD135.3 million, driven by
HEXO Corp (HEXO) Earnings: 4Q20 Key Numbers
HEXO Corp (NYSE: HEXO) reported net revenue of CAD27.1 million for the fourth quarter of 2020, reflecting an increase of 76% from
Aurora Cannabis (ACB) banks on premium brands after disastrous Q4
Shareholders of Aurora Cannabis (NYSE: ACB) were dealt an unexpected blow this week as the pot company's disappointing earnings report thwarted hopes
During tough times, Tilray (TLRY) looks overseas to achieve growth targets
Cannabis was recognized as an essential business in several markets when the shutdown came into effect, including Canada and some US states,
GW Pharmaceuticals PLC (GWPH) Q2 2020 Earnings Call Transcript
GW Pharmaceuticals PLC (NASDAQ: GWPH) Q2 2020 earnings call dated August 06, 2020 Corporate Participants: Stephen Schultz -- Vice President of Investor Relations Justin
Canopy Growth’s (CGC) net loss narrows in Q1 on revenue growth and cost cuts; stock surges
After Canopy Growth (NYSE: CGC) reported its first quarter 2021 results yesterday, the shares jumped about 10% in the pre-market trading and
Tilray Q2 loss widens despite revenue growth; results miss
https://www.youtube.com/watch?v=KqNZ-_X4F8k&t=2s Cannabis company Tilray, Inc. (NASDAQ: TLRY) Monday reported a wider net loss for the second quarter of 2020, despite a marked
Canopy Growth (CGC) Q1 2021 earnings in a nutshell
Canopy Growth (NYSE: CGC) reported an improvement in net loss for its first quarter ended 2021 with a revenue increase of 22%.
Cronos (CRON) Q2 Earnings: Key financials and quarterly highlights
Cronos Group Inc. (NASDAQ: CRON) reported second quarter 2020 earnings results today. Consolidated net revenues grew 29% year-over-year to $9.9 million, driven
Aphria (APHA) swings to a loss in Q4 despite 18% growth in revenue
Aphria (NASDAQ: APHA) stock plunged more than 10% in the pre-market trading session as it reported a loss of C$98 million or
HEXO Corp. (NYSE: HEXO) Q3 2020 Earnings Call Transcript
HEXO Corp. (HEXO) Q3 2020 earnings call dated June 11, 2020 Corporate Participants: Jennifer Smith -- Director of Investor Relations Sebastien St-Louis -- Co-founder and Chief
Infographic: Key highlights of HEXO Corp (HEXO) Q3 2020 earnings
HEXO Corp. (TSX: HEXO; NYSE: HEXO) reported a wider loss in the third quarter of 2020 due to higher expenses. The top-line
Infographic: Highlights of Canopy Growth (CGC) Q4 2020 earnings results
Canopy Growth Corporation (NYSE: CGC) reported its financial results for the quarter ended March 31, 2020, on Friday before the market opens.
Village Farms (VFF): Regulatory uncertainty – a major roadblock for US CBD opportunity
Village Farms International Inc. (NASDAQ: VFF) reported total sales of $39.6 million for the first quarter of 2020 compared to $38.6 million
Aurora Cannabis Inc (NYSE: ACB) Q3 2020 Earnings Call Transcript
Aurora Cannabis Inc (ACB) Q3 2020 earnings call dated May 14, 2020 Corporate Participants: Michael Singer -- Executive Chairman and Interim Chief Executive Officer
Infographic: Highlights of Aurora Cannabis (ACB) Q3 2020 Earnings Report
Aurora Cannabis, Inc. (NYSE: ACB) reported a narrower loss for the third quarter of 2020, aided by a 16% growth in revenues.
Tilray’s (TLRY) loss widens in Q1 despite minimal impact from COVID-19
Tilray (NASDAQ: TLRY) reported mixed results yesterday for its first quarter of 2020. Despite revenue rising more than 100% in the quarter,